2022 ... Get your popcorn out!, page-2

  1. 540 Posts.
    lightbulb Created with Sketch. 993
    https://www.independent.co.uk/news/health/deltacron-covid-variant-pandemic-b2034386.html

    Exactly as Silviu said, there shall be new variants of COVID-19 and some of these may be better or worse.

    The latest variant is DELTACRON, which is hitting the news in Europe this weekend, and looks like more severe than OMICRON.

    Mesoblast doesn’t need to wait for the BLA in order to start another clinical trial. Probably the IND has been submitted and we are now waiting the green light from FDA / NIH.

    NIH is definitely a part of the confirmatory Phase 3 trial for COVID-19 ARDS.

    How will they recruit 300 patients?

    30 medical centers x 10 patients…
    or
    15 medical centers x 20 patients….
    or
    45 medical centers x 7 patients…

    Without competing trials, which was a huge problem for recruiting before, they should be able to recruit in faster time than the first trial, however if needed they can make it an international trial and target hotspots around the world. So I think there shall be NIH for domestic USA recruitment and an international partner (big pharma) as well.

    I anticipate announcements on this in next week(s).



    Last edited by aquazul: 13/03/22
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$1.59
Change
-0.025(1.55%)
Mkt cap ! $2.031B
Open High Low Value Volume
$1.61 $1.62 $1.57 $6.345M 3.987M

Buyers (Bids)

No. Vol. Price($)
6 44493 $1.59
 

Sellers (Offers)

Price($) Vol. No.
$1.59 4159 1
View Market Depth
Last trade - 16.10pm 08/07/2025 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.